Science Advances
Supplementary Materials
This PDF file includes:
- fig. S1. Microfabricated molds for the assay.
- fig. S2. Schematics of the gradient generator design.
- fig. S3. Flow rate of the device and the dynamics within the channel.
- fig. S4. Simulated flow conditions of the assay.
- fig. S5. Consistency of gradient concentration in channels over time.
- fig. S6. Estimation of cell counts after influence of flow.
- fig. S7. Validation of integrated assay for proliferation with MCF-7 cell lines.
- fig. S8. Optimization of cancer cell line culture parameters.
- fig. S9. Phase-contrast images of 2-week cultures under different culture conditions.
- fig. S10. Proportion of CTCs before culture affected the potential of cluster formation.
- fig. S11. Fluorescence in situ hybridization of cultured cells.
- fig. S12. Epithelial CTC counts before and after culture.
- fig. S13. Screening of doxorubicin in microwell assay using clinical human primary cancer cells cultured from blood samples.
- fig. S14. Characterization of cultures.
- fig. S15. Representative images of residual WBC populations.
- fig. S16. Scanning electron microscopy images demonstrating the densely packed array of microwells to maximize surface for capturing CTCs for culture.
- fig. S17. Representative image of a microwell containing cells contaminated by RBCs due to inadequate RBC lysis.
- fig. S18. Optimization of culture medium conditions.
- table S1. Concentration of a single reagent at each serpentine.
- table S2. Samples for preliminary validation of procedure.
- table S3. Samples evaluated for drug screening.
- table S4. Average percentage of viable CD45− cells in clinical samples.
- table S5. Disease evaluation of three sets of serial samples with at least one positive culture generated.
- table S6. CTC counts per milliliter as reported by notable CTC enrichment methods (non–culture-based).
- Legend for movie S1
Other Supplementary Material for this manuscript includes the following:
- movie S1 (.mp4 format). Illustration of seeding, growth, and drug flow.
Files in this Data Supplement: